Rhelion Life Sciences Corp. TRUFF
Set alert
0.01 USD +0.01 —
As of Nov 2, 12:59 PM ET
0.0125 Day range 0.0145
0.005 52-week range 0.043
- YTD
- -9.37%
- 1 year
- -34.09%
- Open
- 0.0139
- Prev close
- 0.00
- Mkt cap
- 8.90M
- Vol
- 46.03K
- Avg vol
- 114.43K
- EPS
- 0.00
- P/E
- 0.00
More statistics
- Low
- 0.0125
- High
- 0.0145
6M chart
Signals (51)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Sep 28, 2026 | 1 month ago |
| SMA: Bearish | Sep 28, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 28, 2026 | 1 month ago |
| SMA: Bullish | Sep 25, 2026 | 1 month ago |
| SMA: Bearish | Sep 24, 2026 | 1 month ago |
| SMA: Bullish | Sep 23, 2026 | 1 month ago |
| SMA: Bearish | Sep 22, 2026 | 1 month ago |
| SMA: Bullish | Sep 21, 2026 | 1 month ago |
| SMA: Bearish | Sep 16, 2026 | 1 month ago |
| SMA: Bullish | Sep 15, 2026 | 1 month ago |
| SMA: Bullish | Sep 14, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 14, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 11, 2026 | 1 month ago |
| SMA: Bearish | Sep 9, 2026 | 1 month ago |
| SMA: Bearish | Sep 9, 2026 | 1 month ago |
| SMA: Bullish | Sep 8, 2026 | 1 month ago |
| SMA: Bullish | Sep 8, 2026 | 1 month ago |
| SMA: Bearish | Sep 3, 2026 | 2 months ago |
| SMA: Bullish | Sep 1, 2026 | 2 months ago |
| MACD: Buy Signal | Sep 1, 2026 | 2 months ago |
Newest 20 of 51.
Financial health
Altman Z-Score
-1.48 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 4
Valuation
P/E -1.4×
FY 2017 5y median -3.3× FY 2026
P/S 2.0×
FY 2017 5y median 4.9× FY 2026
P/B 0.7×
FY 2017 5y median 1.1× FY 2026
P/FCF -3.3×
FY 2017 5y median -6.6× FY 2026
EV/EBITDA -0.2×
FY 2017 5y median -1.0× FY 2026
EV/Sales 0.3×
FY 2017 5y median 2.3× FY 2026
FCF Yield -30.7%
FY 2017 5y median -15.2% FY 2026
Profitability
Gross Margin 37.9%
FY 2017 5y median 38.7% FY 2026
Operating Margin -98.3%
FY 2017 5y median -121.5% FY 2026
Net Margin -145.4%
FY 2017 5y median -145.4% FY 2026
ROE -51.0%
FY 2017 5y median -23.3% FY 2026
ROIC -31.2%
FY 2017 5y median -20.7% FY 2026
ROA -41.9%
FY 2017 5y median -19.0% FY 2026
Growth (YoY)
Revenue -15.1%
FY 2017 FY 2026
Operating Income 2.0%
FY 2017 FY 2026
EPS (diluted) -44.6%
FY 2017 FY 2026
Free Cash Flow -27.2%
FY 2017 FY 2026
Financial Health
Current Ratio 4.0×
FY 2017 5y median 5.5× FY 2026
Quick Ratio 3.7×
FY 2017 5y median 5.2× FY 2026
Debt / Equity 0.1×
FY 2017 5y median 0.1× FY 2026
Net Debt / EBITDA 1.0×
FY 2017 5y median 2.1× FY 2026
Interest Coverage -70.5×
FY 2017 5y median -70.5× FY 2026
Dividends
Dividend Yield 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017 5y median 0.0% FY 2026
Annual · latest fiscal year ends 2026-03-31
